Loading...
XSTO
BIOG B
Market cap1.03bUSD
Dec 05, Last price  
98.50SEK
1D
-0.20%
1Q
-5.38%
Jan 2017
64.17%
Name

Biogaia AB

Chart & Performance

D1W1MN
XSTO:BIOG B chart
P/E
27.61
P/S
6.82
EPS
3.57
Div Yield, %
5.08%
Shrs. gr., 5y
3.12%
Rev. gr., 5y
13.11%
Revenues
1.42b
+9.73%
59,606,00086,792,000106,580,000145,190,000203,461,000236,033,000314,992,000645,252,000315,875,000481,802,000483,241,000534,696,000615,003,000741,870,000768,348,000747,077,000785,111,0001,103,958,0001,296,506,0001,422,718,000
Net income
351m
-3.82%
-19,825,0002,720,00019,659,00036,121,00036,045,00047,168,00076,369,000326,970,00061,722,000147,406,000121,408,000227,568,000180,564,000214,890,000187,347,000179,730,000196,273,000373,773,000365,352,000351,388,000
CFO
373m
-12.38%
-9,969,000-831,0005,088,00019,204,00053,290,00068,965,00072,792,000335,557,00078,441,000124,383,000117,501,000147,929,000222,615,000183,120,000147,855,000221,256,000221,875,000318,943,000425,965,000373,218,000
Dividend
May 08, 20256.9 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
URL
https://sv.biogaia.com/
IPO date
Jan 01, 1998
Employees
215
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT